Over the @ weeks , hypomagnesemia ( @ % ) was the most common treatment-related adverse event , mild to moderate constipation ( @ % ) was the most common gastrointestinal adverse event , and hypokalemia ( < @ mEq/L ) occurred in @ % of patients .